Divalproex Sodium
Product Images NDC 17856-0262

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 17856-0262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 0262 01)

Image Description (17856 0262 01)
This is a medication called Divalproex Sodium, which comes in the form of extended-release tablets with a strength of 500mg. It is a hazardous substance and its indications and dosage schedule can be found in the package insert. The tablets should be stored at a temperature between 59 and 86°F and kept out of reach of children. The product information includes the dosage, quantity, expiration date, lot number, and supplier information. To reorder, call the phone number provided.*
FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)
This appears to be a chart or graph showing the reduction in CPS rate for Divalproex Sodium Delayed-Release compared to a placebo, with a 50% improvement in patients who took the drug. There is also a scale to indicate whether there was no change or worsening in CPS rate.*
FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

FDA Label Image

Image Description (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.